Some syndromes seemed to respond particularly well: bothchildren with AHC, who completed the trial, had ≥50% reduction in seizures/paroxysmalevents; one child with GLUT1-DS and gait difficulties, but without current seizures,became free of paroxysmal events. The gene discussed is SLC2A1; the disease is alternating hemiplegia of childhood.